SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001144204-19-020287
Filing Date
2019-04-18
Accepted
2019-04-18 16:45:52
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC 13D tv519060_sc13d.htm SC 13D 47856
2 EXHIBIT 99.1 tv519060_ex99-1.htm EX-99.1 281699
3 EXHIBIT 99.2 tv519060_ex99-2.htm EX-99.2 73691
4 GRAPHIC tv519060_ex99-2img01.jpg GRAPHIC 3627
  Complete submission text file 0001144204-19-020287.txt   409960
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Subject) CIK: 0001131343 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: SC 13D | Act: 34 | File No.: 005-79901 | Film No.: 19756407
SIC: 2834 Pharmaceutical Preparations

Mailing Address 75 PARK PLAZA THIRD FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA THIRD FLOOR BOSTON MA 02116 2062185982
Life Biosciences LLC (Filed by) CIK: 0001751806 (see all company filings)

IRS No.: 822142145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D